More on GRF
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $10.13 |
|
|||
| Open | $9.97 | ||||
| 52 Wk High | $21.75 | ||||
| 52 Wk Low | $6.41 | ||||
| Day High | $9.97 | ||||
| Day Low | $9.97 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 174 | ||||
- Form 4 EAGLE CAPITAL GROWTH For: Oct 16 Filed by: Sims David C
- Form 4 EAGLE CAPITAL GROWTH For: Sep 01 Filed by: SIMS LUKE E
- Green Rise Foods Announces Q2 Fiscal 2026 Financial Results
- Form N-CSRS EAGLE CAPITAL GROWTH For: Jun 30
- Form N-PX EAGLE CAPITAL GROWTH For: Aug 20
- Grifols completes patient follow-up in phase 3 alpha-1 lung study
- Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency
- Form NPORT-P EAGLE CAPITAL GROWTH For: Jun 30
- Form 6-K Grifols SA For: Jul 30
- Grifols starts two Phase 3 trials to expand immunoglobulin labels
Entities mentioned with GRF
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- 13G | View Related Stories »
- Nomura | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Deutsche Bank | View Related Stories »
- Show More...
